Lifebrain Cerba Healthcare laboratory network
Guidonia, Roma, 00012, Italy
NCT Number: NCT05565651
The microbiota interacts with several human organs and influences the physiological process in the host. The predominant Phyla of species in the gut microbiota are Bacteroidetes (B) and Firmicutes (F), accounting for 60-80%, and Proteobacteria (P) and Actinobacteria (A) in minority. When some of the bacterial Phyla species are unbalanced, the pathological state of dysbiosis occurs. A laboratory index used for clinical analyzes is the F / B ratio <0.8, which characterizes an intestinal dysbiotic state.
Many causes can affect the intestinal microbiota, thus altering it in a dysbiotic state, first of all the diet. In fact, dysbiosis can be characterized both by the severity with which it manifests itself and is also distinguished in putrefactive and fermentative dysbiosis.
Furthermore, the variation in the "normal" percentages of the Phyla is also related to some pathological alterations.
The aim of this study will be to monitor the population and heterogeneity of the microbiota in the Italian population. Knowing the complex implications of dysbiosis and the extensive data on it, this study will want to detail the state of the gut microbiota in the previously indicated population, focusing attention on peculiar profiles that could reflect a pathogenic spectrum or metabolic disturbances.
The study aims to investigate the diffusion and state of the microbiota in the Italian territory and if it occurs in association with certain pathologies and / or diet.
Looking for future studies?
Notify Me16 year–80 year
All sexes
Observational
Guidonia, Roma, 00012, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Data analysis
Time frame: 2020-2022
Change in the percentage of Proteobacteria in type 2 diabetic patients
University of Palermo
Other
Retrospective Study for the Characterization of the Intestinal Microbiota in Association With Pathologies and Diet in the Italian Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06745245
Chronic Disease, Chronic Kidney Disease(CKD)
Toluca, Mexico
View Trial DetailsNCT04304014
Dysbiosis, Pathologic Processes
Sant Cugat del Vallès, Barcelona, Spain
View Trial DetailsNCT05812157
Ankylosis, Arthritis
Nîmes, Gard, France
View Trial DetailsNCT06877585
Dysbiosis, Pathologic Processes
Taichung, Wuqi District, Taiwan
View Trial Details